Novavax Stock Jumps 8.5% After ‘Positive’ Early Results For Its Coronavirus Vaccine

The Maryland-based biotech company received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine.

Source: Forbes.com Healthcare News - August 5, 2020 Category: Pharmaceuticals Authors: Elana Lyn Gross, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Billionaires Source Type: news